16,258 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Acquired by Proficio Capital Partners LLC
Proficio Capital Partners LLC bought a new stake in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 16,258 shares of the biopharmaceutical company’s stock, valued at approximately $339,000. Other hedge funds and other […]
